These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8891915)

  • 61. High-pressure liquid chromatography/electrochemical detection method for monitoring MDA and MDMA in whole blood and other biological tissues.
    Michel RE; Rege AB; George WJ
    J Neurosci Methods; 1993 Oct; 50(1):61-6. PubMed ID: 7903993
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Screening of amphetamine/methamphetamine and their derivatives in urine using FPIA and Triage 8 and the Scope and limits of a subsequent identification by means of the REMEDi HS system.
    Felscher D; Schulz K
    J Forensic Sci; 2000 Nov; 45(6):1327-31. PubMed ID: 11110193
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Analysis of MDMA and its metabolites in urine by GC and GC/MS].
    Shen M; Yan W; Shen B; Xiang P; Huang Z; Liu W; Bo J
    Fa Yi Xue Za Zhi; 1998; 14(1):10-1, 24, 61. PubMed ID: 11360579
    [TBL] [Abstract][Full Text] [Related]  

  • 64. MDMA and MDA cross reactivity observed with Abbott TDx amphetamine/methamphetamine reagents.
    Ramos JM; Fitzgerald RL; Poklis A
    Clin Chem; 1988 May; 34(5):991. PubMed ID: 2897259
    [No Abstract]   [Full Text] [Related]  

  • 65. Stereospecific analysis of ecstasy-like N-ethyl-3,4-methylenedioxyamphetamine and its metabolites in humans.
    Brunnenberg M; Kovar KA
    J Chromatogr B Biomed Sci Appl; 2001 Feb; 751(1):9-18. PubMed ID: 11232860
    [TBL] [Abstract][Full Text] [Related]  

  • 66. MDA, MDMA, and other "mescaline-like" substances in the US military's search for a truth drug (1940s to 1960s).
    Passie T; Benzenhöfer U
    Drug Test Anal; 2018 Jan; 10(1):72-80. PubMed ID: 28851034
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Simultaneous analysis of six amphetamines and analogues in hair, blood and urine by LC-ESI-MS/MS. Application to the determination of MDMA after low ecstasy intake.
    Chèze M; Deveaux M; Martin C; Lhermitte M; Pépin G
    Forensic Sci Int; 2007 Aug; 170(2-3):100-4. PubMed ID: 17629643
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Determination of paramethoxyamphetamine and other amphetamine-related designer drugs by liquid chromatography/sonic spray ionization mass spectrometry.
    Mortier KA; Dams R; Lambert WE; De Letter EA; Van Calenbergh S; De Leenheer AP
    Rapid Commun Mass Spectrom; 2002; 16(9):865-70. PubMed ID: 11948818
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Metabolism of the new designer drug alpha-pyrrolidinopropiophenone (PPP) and the toxicological detection of PPP and 4'-methyl-alpha-pyrrolidinopropiophenone (MPPP) studied in rat urine using gas chromatography-mass spectrometry.
    Springer D; Fritschi G; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Nov; 796(2):253-66. PubMed ID: 14581066
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Identification of 3-O-methyl-alpha-methyldopamine as a urinary metabolite of 3,4-methylenedioxyamphetamine in dog and monkey.
    Midha KK; Cooper JK; By A; Ethier JC
    Drug Metab Dispos; 1977; 5(2):143-8. PubMed ID: 15806
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Amphetamine concentrations in human urine following single-dose administration of the calcium antagonist prenylamine-studies using fluorescence polarization immunoassay (FPIA) and GC-MS.
    Kraemer T; Roditis SK; Peters FT; Maurer HH
    J Anal Toxicol; 2003 Mar; 27(2):68-73. PubMed ID: 12669999
    [TBL] [Abstract][Full Text] [Related]  

  • 72. In vivo formation of aromatic hydroxylated metabolites of 3,4-(methylenedioxy)methamphetamine in the rat: identification by ion trap tandem mass spectrometric (MS/MS and MS/MS/MS) techniques.
    Lim HK; Foltz RL
    Biol Mass Spectrom; 1991 Nov; 20(11):677-86. PubMed ID: 1686830
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Metabolism and toxicological detection of a new designer drug, N-(1-phenylcyclohexyl)propanamine, in rat urine using gas chromatography-mass spectrometry.
    Sauer C; Peters FT; Staack RF; Fritschi G; Maurer HH
    J Chromatogr A; 2008 Apr; 1186(1-2):380-90. PubMed ID: 18035363
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Simultaneous determination of HFBA-derivatized amphetamines and ketamines in urine by gas chromatography-mass spectrometry.
    Lee HH; Lee JF; Lin SY; Chen PH; Chen BH
    J Anal Toxicol; 2011 Apr; 35(3):162-9. PubMed ID: 21439152
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A Case of 3,4-Dimethoxyamphetamine (3,4-DMA) and 3,4-Methylenedioxymethamphetamine (MDMA) Toxicity with Possible Metabolic Interaction.
    Darracq MA; Thornton SL; Minns AB; Gerona RR
    J Psychoactive Drugs; 2016; 48(5):351-354. PubMed ID: 27636207
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Application of the Syva EMIT and Abbott TDx amphetamine immunoassays to the detection of 3,4-methylene-dioxymethamphetamine (MDMA) and 3,4-methylene-dioxyethamphetamine (MDEA) in urine.
    Kunsman GW; Manno JE; Cockerham KR; Manno BR
    J Anal Toxicol; 1990; 14(3):149-53. PubMed ID: 1973747
    [TBL] [Abstract][Full Text] [Related]  

  • 77. New designer drug 1-(3-trifluoromethylphenyl) piperazine (TFMPP): gas chromatography/mass spectrometry and liquid chromatography/mass spectrometry studies on its phase I and II metabolism and on its toxicological detection in rat urine.
    Staack RF; Fritschi G; Maurer HH
    J Mass Spectrom; 2003 Sep; 38(9):971-81. PubMed ID: 14505325
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Detection of 1-benzylpiperazine, 1-(3-trifluoromethylphenyl)-piperazine, and 1-(3-chlorophenyl)-piperazine in 3,4-methylenedioxymethamphetamine-positive urine samples.
    Dickson AJ; Vorce SP; Holler JM; Lyons TP
    J Anal Toxicol; 2010 Oct; 34(8):464-9. PubMed ID: 21819791
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A comparison of the validity of gas chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry analysis of urine samples II: amphetamine, methamphetamine, (±)-3,4-methylenedioxyamphetamine, (±)-3,4-methylenedioxymethamphetamine, (±)-3,4-methylenedioxyethylamphetamine, phencyclidine, and (±)-11-nor-9-carboxy-Δ⁹-tetrahydrocannabinol.
    Stout PR; Bynum ND; Lewallen CM; Mitchell JM; Baylor MR; Ropero-Miller JD
    J Anal Toxicol; 2010 Oct; 34(8):430-43. PubMed ID: 21819787
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Morbidity involving the hallucinogenic designer amines MDA and 2C-I.
    Drees JC; Stone JA; Wu AH
    J Forensic Sci; 2009 Nov; 54(6):1485-7. PubMed ID: 19878416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.